Therapeutic Targets Database
BIDD Pharmainformatics Databases


Target Validation Information
Target NameEquilibrative nucleoside transporter 1    
Type of TargetSuccessful target    
Drug Potency against TargetS6-nitrobenzyl mercaptopurine ribosideKi = 0.7 nM[1]
9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purineKi = 135 nM[3]
6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purineKi = 2200 nM[3]
LIDOFLAZINEKi = 279.9 nM[4]
Ref 1Bioorg Med Chem Lett. 2009 Feb 1;19(3):917-21. Epub 2008 Dec 6.Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors. To Reference
Ref 2J Med Chem. 2005 Jan 13;48(1):321-9.Inhibition of nucleoside transport proteins by C8-alkylamine-substituted purines. To Reference
Ref 3J Med Chem. 2004 Oct 21;47(22):5441-50.Inhibition of nucleoside transport by new analogues of 4-nitrobenzylthioinosine: replacement of the ribose moiety by substituted benzyl groups. To Reference
Ref 4J Med Chem. 2007 Aug 9;50(16):3906-20. Epub 2007 Jul 18.Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543